Concepedia

Ben Wynne

BW

Statistics

Publications

4

Citations

168

H-Index

4

Active since

2021

Affiliations

Joint Clinical Research Centre(Current)

University of KwaZulu-Natal

University of Zimbabwe

MRC Clinical Trials Unit at UCL

Perinatal HIV Research Unit

Ben Wynne is an author at Joint Clinical Research Centre specializing in antiretroviral therapy, pediatric clinical trials, and pharmacy.

Publications per year

2021–2023

4

Publications

4

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

Anna Turkova, Ellen White, Cissy Kityo et al. · UCL Discovery (University College London) · 2021 · 103 citations

, , +16

Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trial

Pauline Amuge, Abbas Lugemwa, Ben Wynne et al. · The Lancet HIV · 2022 · 31 citations · Full text

, , +15

Dolutegravir twice-daily dosing in children with HIV-associated tuberculosis: a pharmacokinetic and safety study within the open-label, multicentre, randomised, non-inferiority ODYSSEY trial

Anna Turkova, Hylke Waalewijn, Man K. Chan et al. · The Lancet HIV · 2022 · 24 citations · Full text

, , +17

Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial

Anna Turkova, Ellen White, Adeodata Kekitiinwa et al. · The Lancet Child & Adolescent Health · 2023 · 10 citations · Full text

, , +17

1–4 of 4